Back to Directory
Molecular Devices
Founded 1983
Bioanalytical instruments and patient-derived organoid expansion services
Molecular Devices develops bioanalytical instruments, laboratory automation and cell-based research technologies for drug discovery.
Its portfolio includes microplate readers, high-content imaging systems, clone screening instruments and laboratory analysis software.
The company acquired Cardiff organoid specialist Cellesce in 2022. Its Molecular Devices (Cardiff) operation supplies scaled, quality-controlled patient-derived organoids for research screening, supported by proprietary bioreactor technology. UK commercial services are based at Winnersh Triangle, while organoid expansion operates in Cardiff.
Company Notes
AKA / Aliases
Cellesce (acquired); Molecular Devices Cardiff